Top Markets
Coin of the day
FunPep Company Limited FunPep Company Limited

FunPep Company Limited

4881
Classifica tra le azioni #30951
FunPep Company Limited specializes in the discovery and advancement of... FunPep Company Limited specializes in the discovery and advancement of pharmaceutical drugs, functional cosmetics, and medical devices, leveraging its core technology in functional peptides. The company's development pipeline prominently features SR-0379, a functional peptide designed to address skin ulcers. FunPep is advancing FPP003, an antibody-inducing peptide, which is undergoing Phase II clinical trials for psoriasis in Australia and for ankylosing spondylitis in Japan. Another antibody-inducing peptide, FPP004X, is also in development, targeting pollinosis. Additionally, the company is working on FPP006, a corona peptide vaccine, and FPP005, an antibody-inducing peptide for psoriasis. Established in 2013, FunPep Company Limited operates from its headquarters in Tokyo, Japan.
Prezzo delle azioni
$0.33274288
Capitalizzazione di mercato
$14.92M
Variazione (1 giorno)
2.00%
Variazione (1 anno)
-57.59%
Paese
JP
Scambia FunPep Company Limited (4881)

Categoria

Rapporto P/S per FunPep Company Limited (4881)
Rapporto P/S al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di FunPep Company Limited, il rapporto P/S attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/S per FunPep Company Limited da 2026 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
Non abbastanza dati per le date fornite.
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
10.17 -
US
10.13 -
NL
2.95 -
AU
- -
CH
4.74 -
BE